CSNK1A1 and liposarcoma: Wnt/β-catenin signaling has been associated with miR-155 in liposarcoma; CK1α (casein kinase 1α), a key regulator of Wnt/β-catenin pathway, is targeted by miR-155, leading to β-catenin signaling and CCND1 activation, cell proliferation and liposarcoma progression [36].